SDAI Reshapes Top Leadership as Subsidiary Chief Liu Ting Becomes Group CEO
I'm PortAI, I can summarize articles.
SDAI Limited has appointed Liu Ting, CEO of Hainan Blue Code Biotechnology, as the new group CEO, effective January 16, 2026. Current CEO Yap Koon Loong will transition to an executive director role. This leadership reshuffle aims to enhance board-level representation and promote internal leadership within the biotechnology sector, while maintaining the existing board composition and governance committees. SDAI is a Singapore-based holding company with a market cap of S$33.97M, focusing on biotechnology operations in China.
Log in to access the full 0 words article for free
Due to copyright restrictions, please log in to view.
Thank you for supporting legitimate content.
Source: Tip Ranks The copyright of this article belongs to the original author/organization.
The views expressed herein are solely those of the author and do not reflect the stance of the platform. The content is intended for investment reference purposes only and shall not be considered as investment advice. Please contact us if you have any questions or suggestions regarding the content services provided by the platform.
Post your comment
No Comments